Patent Cliff Pharma

BMY 7x earnings, PFE post-COVID: market overprices patent cliffs by 2-3x

Total Return

+12.4%

Sharpe Ratio

0.05

Max Drawdown

-13.8%

Win Rate

51.7%

Alpha

-62.4%

Comp. Score *

0.06

Risk Parameters

Max Allocation3.8%

Stop Loss16.5%

Take Profit10.0%

Max DD Tolerance13.8%

Rebalanceweekly

Execution Guidance

Order TypeLimit

Entry RuleBuy below SMA200 or at RSI < 35. Value = patience. Don't rush.

TimingSAFE TO BUY. *

ScalingEnter in 3 tranches over 4-6 weeks as price confirms bottom.

Positions — Vol-Adjusted Sizing

Symbol	Action	Vol	Stop Loss	Take Profit	Size	Links
TAK	BUY	20%	14.1% below entry	8.5% above entry	4.4%	TV YH